Clinical Trial Update: Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II trial assessing the efficacy and toxicity of capecitabine and oxaliplatin in colorectal cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED